549
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Implications of vitamin D deficiency in systemic inflammation and cardiovascular health

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • Aihara, K., H. Azuma, M. Akaike, Y. Ikeda, M. Yamashita, T. Sudo, H. Hayashi, Y. Yamada, F. Endoh, M. Fujimura, et al. 2004. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. The Journal of Biological Chemistry 279 (34):35798–802. doi: 10.1074/jbc.M404865200.
  • Alhassan Mohammed, H., A. A. Saboor-Yaraghi, A. Mirshafiey, H. Vahedi, M. R. Shiri-Shahsavar, and A. Mousavi Nasl Khameneh. 2017. Immunomodulatory and immunosuppressive roles of 1α,25(OH)2D3 in autoimmune diseases. Scandinavian Journal of Immunology 85 (2):95–103. doi: 10.1111/sji.12512.
  • Al Mheid, I., R. Patel, J. Murrow, A. Morris, A. Rahman, L. Fike, N. Kavtaradze, I. Uphoff, C. Hooper, V. Tangpricha, et al. 2011. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. Journal of the American College of Cardiology 58 (2):186–92. doi: 10.1016/j.jacc.2011.02.051.
  • Alibaz-Oner, F., K. Aksu, S. P. Yentur, G. Keser, G. Saruhan-Direskeneli, and H. Direskeneli. 2016. Plasma pentraxin-3 levels in patients with Takayasu’s arteritis during routine follow-up. Clinical and Experimental Rheumatology 34:S73–S6.
  • Almerighi, C., A. Sinistro, A. Cavazza, C. Ciaprini, G. Rocchi, and A. Bergamini. 2009. 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 45 (3):190–7. doi: 10.1016/j.cyto.2008.12.009.
  • Alzaim, M., and R. J. Wood. 2013. Vitamin D and gestational diabetes mellitus. Nutrition Reviews 71 (3):158–67. doi: 10.1111/nure.12018.
  • Amrein, K., M. Scherkl, M. Hoffmann, S. Neuwersch-Sommeregger, M. Köstenberger, A. Tmava Berisha, G. Martucci, S. Pilz, and O. Malle. 2020. Vitamin D deficiency 2.0: An update on the current status worldwide. European Journal of Clinical Nutrition 74 (11):1498–513. doi: 10.1038/s41430-020-0558-y.
  • Anderson, J. L., H. T. May, B. D. Horne, T. L. Bair, N. L. Hall, J. F. Carlquist, D. L. Lappé, and J. B. Muhlestein. 2010. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. The American Journal of Cardiology 106 (7):963–8. doi: 10.1016/j.amjcard.2010.05.027.
  • Andrukhova, O., S. Slavic, U. Zeitz, S. C. Riesen, M. S. Heppelmann, T. D. Ambrisko, M. Markovic, W. M. Kuebler, and R. G. Erben. 2014. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Molecular Endocrinology (Baltimore, Md.) 28 (1):53–64. doi: 10.1210/me.2013-1252.
  • Anjum, I., S. S. Jaffery, M. Fayyaz, Z. Samoo, and S. Anjum. 2018. The role of vitamin D in brain health: A mini literature review. Cureus 10 (7):e2960. doi: 10.7759/cureus.2960.
  • Apaydın, M., S. Beysel, N. Eyerci, F. A. Pinarli, M. Ulubay, M. Kizilgul, O. Ozdemir, M. Caliskan, and E. Cakal. 2019. The VDR gene FokI polymorphism is associated with gestational diabetes mellitus in Turkish women. BMC Medical Genetics 20 (1):6. doi: 10.1186/s12881-019-0820-0.
  • Aparna, P., S. Muthathal, B. Nongkynrih, and S. K. Gupta. 2018. Vitamin D deficiency in India. Journal of Family Medicine and Primary Care 7 (2):324–30. doi: 10.4103/jfmpc.jfmpc_78_18.
  • Arnson, Y., H. Amital, N. Agmon-Levin, D. Alon, M. Sánchez-Castañón, M. López-Hoyos, M. Matucci-Cerinic, G. Szücs, Y. Shapira, Z. Szekanecz, et al. 2011. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature. Autoimmunity Reviews 10 (8):490–4. doi: 10.1016/j.autrev.2011.02.002.
  • Assa, A., L. Vong, L. J. Pinnell, N. Avitzur, K. C. Johnson-Henry, and P. M. Sherman. 2014. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. The Journal of Infectious Diseases 210 (8):1296–305. doi: 10.1093/infdis/jiu235.
  • Banakar, M. C., S. K. Paramasivan, M. B. Chattopadhyay, S. Datta, P. Chakraborty, M. Chatterjee, K. Kannan, and E. Thygarajan. 2004. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World Journal of Gastroenterology 10 (9):1268–75. doi: 10.3748/wjg.v10.i9.1268.
  • Banerjee, A., V. K. Khemka, A. Ganguly, D. Roy, U. Ganguly, and S. Chakrabarti. 2015. Vitamin D and Alzheimer’s disease: Neurocognition to therapeutics. International Journal of Alzheimer’s Disease 2015:192747. doi: 10.1155/2015/192747.
  • Barger-Lux, M. J., R. P. Heaney, S. J. Lanspa, J. C. Healy, and H. F. DeLuca. 1995. An investigation of sources of variation in calcium absorption efficiency. The Journal of Clinical Endocrinology and Metabolism 80 (2):406–11. doi: 10.1210/jcem.80.2.7852497.
  • Barragan, M., M. Good, and J. K. Kolls. 2015. Regulation of dendritic cell function by vitamin D. Nutrients 7 (9):8127–51. doi: 10.3390/nu7095383.
  • Bessler, H., and M. Djaldetti. 2012. 1α,25-Dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 66 (6):428–32. doi: 10.1016/j.biopha.2012.06.005.
  • Bettelli, E., T. Korn, and V. K. Kuchroo. 2007. Th17: The third member of the effector T cell trilogy. Current Opinion in Immunology 19 (6):652–7. doi: 10.1016/j.coi.2007.07.020.
  • Beveridge, L. A., A. D. Struthers, F. Khan, R. Jorde, R. Scragg, H. M. Macdonald, J. A. Alvarez, R. S. Boxer, A. Dalbeni, A. D. Gepner, et al. 2015. Effect of vitamin D supplementation on blood pressure: A systematic review and meta-analysis incorporating individual patient data. JAMA Internal Medicine 175 (5):745–54. doi: 10.1001/jamainternmed.2015.0237.
  • Bhargava, P., E. Sotirchos, C. Eckstein, A. Ntranos, A. Gocke, E. Mowry, and P. Calabresi. 2015. High-dose vitamin D supplementation reduces IL-17-producing CD4+ T-cells and effector-memory CD4+ T-cells in multiple sclerosis patients (S38. 001).
  • Bikle, D. D. 2014. Vitamin D metabolism, mechanism of action, and clinical applications. Chemistry & Biology 21 (3):319–29. doi: 10.1016/j.chembiol.2013.12.016. 24529992
  • Bleizgys, A. 2021. Vitamin D dosing: Basic principles and a brief algorithm (2021 Update). Nutrients 13 (12):4415. doi: 10.3390/nu13124415.
  • Boonstra, A., F. J. Barrat, C. Crain, V. L. Heath, H. F. Savelkoul, and A. O’Garra. 2001. 25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. Journal of Immunology (Baltimore, Md.: 1950) 167 (9):4974–80. doi: 10.4049/jimmunol.167.9.4974.
  • Vibhor V, Borkar, Savita, Verma, A K, Bhalla, Devidayal,. 2010. ‘Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes’. Pediatric Diabetes, 5, 11: 345–50. doi: 10.1111/j.1399-5448.2009.00589.x.
  • Bouillon, R., and L. Antonio. 2020. Nutritional rickets: Historic overview and plan for worldwide eradication. The Journal of Steroid Biochemistry and Molecular Biology 198:105563. doi: 10.1016/j.jsbmb.2019.105563.
  • Briones, T. L., and H. Darwish. 2012. Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. Journal of Neuroinflammation 9:244. doi: 10.1186/1742-2094-9-244.
  • Calvello, R., A. Cianciulli, G. Nicolardi, F. De Nuccio, L. Giannotti, R. Salvatore, C. Porro, T. Trotta, M. A. Panaro, and D. D. Lofrumento. 2017. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia responses. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology 12 (2):327–39. doi: 10.1007/s11481-016-9720-7.
  • Canning, M. O., K. Grotenhuis, H. de Wit, C. Ruwhof, and H. A. Drexhage. 2001. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25 (OH)(2) D (3)) hampers the maturation of fully active immature dendritic cells from monocytes. European Journal of Endocrinology 145 (3):351–7. doi: 10.1530/eje.0.1450351.
  • Cantorna, M. T., L. Snyder, Y. D. Lin, and L. Yang. 2015. Vitamin D and 1, 25 (OH) 2D regulation of T cells. Nutrients 7 (4):3011–21. doi: 10.3390/nu7043011.
  • Cardoso-Silva, D., D. Delbue, A. Itzlinger, R. Moerkens, S. Withoff, F. Branchi, and M. Schumann. 2019. Intestinal barrier function in gluten-related disorders. Nutrients 11 (10):2325. doi: 10.3390/nu11102325.
  • Cardús, A., E. Parisi, C. Gallego, M. Aldea, E. Fernández, and J. M. Valdivielso. 2006. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney International 69 (8):1377–84. doi: 10.1038/sj.ki.5000304.
  • Chang, S.-W., and H.-C. Lee. 2019. Vitamin D and health-The missing vitamin in humans. Pediatrics and Neonatology 60 (3):237–44. doi: 10.1016/j.pedneo.2019.04.007.
  • Chen, S., G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky. 2007. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. The Journal of Immunology 179 (3):1634–47. doi: 10.4049/jimmunol.179.3.1634.
  • Chitalia, N., A. Recio-Mayoral, J. C. Kaski, and D. Banerjee. 2012. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220 (1):265–8. doi: 10.1016/j.atherosclerosis.2011.10.023.
  • Christakos, S. 2012. Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Archives of Biochemistry and Biophysics 523 (1):73–6. doi: 10.1016/j.abb.2011.12.020.
  • Chung, C., P. Silwal, I. Kim, R. L. Modlin, and E.-K. Jo. 2020. Vitamin D-cathelicidin axis: At the crossroads between protective immunity and pathological inflammation during infection. Immune Network 20 (2):e12. doi: 10.4110/in.2020.20.e12.
  • Colin, E. M., A. E. Weel, A. G. Uitterlinden, C. J. Buurman, J. C. Birkenhäger, H. A. Pols, and J. P. Van Leeuwen. 2000. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25‐dihydroxyvitamin D3. Clinical Endocrinology 52 (2):211–6. doi: 10.1046/j.1365-2265.2000.00909.x.
  • Correale, J., M. C. Ysrraelit, and M. I. Gaitán. 2010. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. Journal of Immunology (Baltimore, Md.: 1950) 185 (8):4948–58. doi: 10.4049/jimmunol.1000588.
  • de Boer, I. H., B. Kestenbaum, A. B. Shoben, E. D. Michos, M. J. Sarnak, and D. S. Siscovick. 2009. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. Journal of the American Society of Nephrology: JASN 20 (8):1805–12. doi: 10.1681/ASN.2008111157.
  • de Oliveira, L. R. C., L. A. N. Mimura, T. F. C. Fraga-Silva, L. L. W. Ishikawa, A. A. H. Fernandes, S. F. G. Zorzella-Pezavento, and A. Sartori. 2020. Calcitriol prevents neuroinflammation and reduces blood-brain barrier disruption and local macrophage/microglia activation. Frontiers in Pharmacology 11:161. doi: 10.3389/fphar.2020.00161.
  • Deleskog, A., A. Hilding, K. Brismar, A. Hamsten, S. Efendic, and C. G. Östenson. 2012. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 55 (6):1668–78. doi: 10.1007/s00125-012-2529-x.
  • DeLuca, H. F. 2004. Overview of general physiologic features and functions of vitamin D. The American Journal of Clinical Nutrition 80 (6 Suppl):1689S–96S. doi: 10.1093/ajcn/80.6.1689S.
  • Di Rosa, M., M. Malaguarnera, F. Nicoletti, and L. Malaguarnera. 2011. Vitamin D3: A helpful immuno‐modulator. Immunology 134 (2):123–39. doi: 10.1111/j.1365-2567.2011.03482.x.
  • Dionne, S., M. R. Calderon, J. H. White, B. Memari, I. Elimrani, B. Adelson, C. Piccirillo, and E. G. Seidman. 2014. Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn’s disease. Mucosal Immunology 7 (6):1405–15. doi: 10.1038/mi.2014.30.
  • Dobnig, H., S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, B. Wellnitz, J. Kinkeldei, B. O. Boehm, G. Weihrauch, and W. Maerz. 2008. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Archives of Internal Medicine 168 (12):1340–9. doi: 10.1001/archinte.168.12.1340.
  • Doubelt, I., D. Cuthbertson, S. Carette, N. A. Khalidi, C. L. Koening, C. Langford, C. A. McAlear, L. W. Moreland, P. Monach, P. Seo, et al. 2023. Vitamin D status in ANCA-associated vasculitis. Rheumatology Advances in Practice 7 (1):rkad021. doi: 10.1093/rap/rkad021.
  • Dupuis, M. L., M. T. Pagano, M. Pierdominici, and E. Ortona. 2021. The role of vitamin D in autoimmune diseases: Could sex make the difference? Biology of Sex Differences 12 (1):12. doi: 10.1186/s13293-021-00358-3.
  • El-Sharkawy, A., and A. Malki. 2020. Vitamin D signaling in inflammation and cancer: Molecular mechanisms and therapeutic implications. Molecules 25 (14):3219. doi: 10.3390/molecules25143219.
  • Evans, M. A., H. A. Kim, Y. H. Ling, S. Uong, A. Vinh, T. M. De Silva, T. V. Arumugam, A. N. Clarkson, G. R. Zosky, G. R. Drummond, et al. 2018. Vitamin D(3) supplementation reduces subsequent brain injury and inflammation associated with ischemic stroke. Neuromolecular Medicine 20 (1):147–59. doi: 10.1007/s12017-018-8484-z.
  • Farhangi, M. A., M. Mesgari-Abbasi, G. Nameni, G. Hajiluian, and P. Shahabi. 2017. The effects of vitamin D administration on brain inflammatory markers in high fat diet induced obese rats. BMC Neuroscience 18 (1):81. doi: 10.1186/s12868-017-0400-1.
  • Forman, J. P., J. S. Williams, and N. D. Fisher. 2010. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension (Dallas, Tex.: 1979) 55 (5):1283–8. doi: 10.1161/HYPERTENSIONAHA.109.148619.
  • Forouhi, N. G., Z. Ye, A. P. Rickard, K. T. Khaw, R. Luben, C. Langenberg, and N. J. Wareham. 2012. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 55 (8):2173–82. doi: 10.1007/s00125-012-2544-y.
  • Fullard, M. E., and J. E. Duda. 2020. A review of the relationship between vitamin D and Parkinson disease symptoms. Frontiers in Neurology 11:454. doi: 10.3389/fneur.2020.00454.
  • Gao, J., W. Wei, G. Wang, H. Zhou, Y. Fu, and N. Liu. 2018. Circulating vitamin D concentration and risk of prostate cancer: A dose-response meta-analysis of prospective studies. Therapeutics and Clinical Risk Management 14:95–104. doi: 10.2147/TCRM.S149325.
  • Gupta, A. 2014. Vitamin D deficiency in India: Prevalence, causalities and interventions. Nutrients 6 (2):729–75. doi: 10.3390/nu6020729.
  • Gentile, C., and F. Chiarelli. 2021. Rickets in children: An update. Biomedicines 9 (7):738. doi: 10.3390/biomedicines9070738.
  • Giulietti, A., E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu. 2007. Monocytes from type 2 diabetic patients have a pro-inflammatory profile 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Research and Clinical Practice 77 (1):47–57. doi: 10.1016/j.diabres.2006.10.007.
  • Gorman, S., L. A. Kuritzky, M. A. Judge, K. M. Dixon, J. P. McGlade, R. S. Mason, J. J. Finlay-Jones, and P. H. Hart. 2007. Topically applied 1, 25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+ CD25+ cells in the draining lymph nodes. Journal of Immunology (Baltimore, Md.: 1950) 179 (9):6273–83. doi: 10.4049/jimmunol.179.9.6273.
  • Golzarand, M., S. Shab-Bidar, G. Koochakpoor, J. R. Speakman, and K. Djafarian. 2016. Effect of vitamin D3 supplementation on blood pressure in adults: An updated meta-analysis. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 26 (8):663–73. doi: 10.1016/j.numecd.2016.04.011.
  • Goyal, H., A. Perisetti, M. R. Rahman, A. Levin, and G. Lippi. 2019. Vitamin D and gastrointestinal cancers: A narrative review. Digestive Diseases and Sciences 64 (5):1098–109. doi: 10.1007/s10620-018-5400-1.
  • Grainger, J. R., E. A. Wohlfert, I. J. Fuss, N. Bouladoux, M. H. Askenase, F. Legrand, L. Y. Koo, J. M. Brenchley, I. D. Fraser, and Y. Belkaid. 2013. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nature Medicine 19 (6):713–21. doi: 10.1038/nm.3189.
  • Grandi, N. C., L. P. Breitling, C. Y. Vossen, H. Hahmann, B. Wüsten, W. März, D. Rothenbacher, and H. Brenner. 2010. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. American Heart Journal 159 (6):1044–51. doi: 10.1016/j.ahj.2010.03.031.
  • Gregori, S., M. Casorati, S. Amuchastegui, S. Smiroldo, A. M. Davalli, and L. Adorini. 2001. Regulatory T cells induced by 1α, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. Journal of Immunology (Baltimore, Md.: 1950) 167 (4):1945–53. doi: 10.4049/jimmunol.167.4.1945.
  • Harrison, D. G., T. J. Guzik, H. E. Lob, M. S. Madhur, P. J. Marvar, S. R. Thabet, A. Vinh, and C. M. Weyand. 2011. Inflammation, immunity, and hypertension. Hypertension (Dallas, Tex.: 1979) 57 (2):132–40. doi: 10.1161/HYPERTENSIONAHA.110.163576.
  • Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. Journal of Immunology (Baltimore, Md.: 1950) 179 (6):4135–41. doi: 10.4049/jimmunol.179.6.4135.
  • Hewison, M. 2012. Vitamin D and the immune system: New perspectives on an old theme. Rheumatic Diseases Clinics of North America 38 (1):125–39. doi: 10.1016/j.rdc.2012.03.012.
  • Hewison, M., L. Freeman, S. V. Hughes, K. N. Evans, R. Bland, A. G. Eliopoulos, M. D. Kilby, P. A. H. Moss, and R. Chakraverty. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. Journal of Immunology (Baltimore, Md.: 1950) 170 (11):5382–90. doi: 10.4049/jimmunol.170.11.5382.
  • Hewison, M., D. Zehnder, R. Chakraverty, and J. S. Adams. 2004. Vitamin D and barrier function: A novel role for extra-renal 1α-hydroxylase. Molecular and Cellular Endocrinology 215 (1-2):31–8. doi: 10.1016/j.mce.2003.11.017.
  • Hombali, A. S., J. A. Solon, B. T. Venkatesh, N. S. Nair, and J. P. Peña-Rosas. 2019. Fortification of staple foods with vitamin A for vitamin A deficiency. Cochrane Database Syst Rev 5:Cd010068.
  • Horton-French, K., E. Dunlop, R. M. Lucas, G. Pereira, and J. L. Black. 2021. Prevalence and predictors of vitamin D deficiency in a nationally representative sample of Austrailian adolescents and young adults. European Journal of Clinical Nutrition 75 (11):1627–36. doi: 10.1038/s41430-021-00880-y.
  • Infante, M., C. Ricordi, J. Sanchez, M. J. Clare-Salzler, N. Padilla, V. Fuenmayor, C. Chavez, A. Alvarez, D. Baidal, R. Alejandro, et al. 2019. Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes. Nutrients 11 (9):2185. doi: 10.3390/nu11092185.
  • Jabri, B., and L. M. Sollid. 2017. T cells in celiac disease. Journal of Immunology (Baltimore, Md.: 1950) 198 (8):3005–14. doi: 10.4049/jimmunol.1601693.
  • Jääskeläinen, T., S. T. Itkonen, A. Lundqvist, M. Erkkola, T. Koskela, K. Lakkala, K. G. Dowling, G. L. Hull, H. Kröger, J. Karppinen, et al. 2017. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: Evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. The American Journal of Clinical Nutrition 105 (6):1512–20. doi: 10.3945/ajcn.116.151415.
  • Jeon, S. M., and E. A. Shin. 2018. Exploring vitamin D metabolism and function in cancer. Experimental & Molecular Medicine 50 (4):1–14. doi: 10.1038/s12276-018-0038-9.
  • Joshi, S., L.-C. Pantalena, X. K. Liu, S. L. Gaffen, H. Liu, C. Rohowsky-Kochan, K. Ichiyama, A. Yoshimura, L. Steinman, S. Christakos, et al. 2011. 1, 25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Molecular and Cellular Biology 31 (17):3653–69. doi: 10.1128/MCB.05020-11.
  • Kállay, E., P. Bareis, E. Bajna, S. Kriwanek, E. Bonner, S. Toyokuni, and H. S. Cross. 2002. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 40 (8):1191–6. doi: 10.1016/s0278-6915(02)00030-3.
  • Karhapää, P., J. Pihlajamäki, I. Pörsti, M. Kastarinen, J. Mustonen, O. Niemelä, and J. Kuusisto. 2010. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. Journal of Internal Medicine 268 (6):604–10. doi: 10.1111/j.1365-2796.2010.02279.x.
  • Kasuga, H., N. Hosogane, K. Matsuoka, I. Mori, Y. Sakura, K. Shimakawa, T. Shinki, T. Suda, and S. Taketomi. 2002. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochemical and Biophysical Research Communications 297 (5):1332–8. doi: 10.1016/s0006-291x(02)02254-4.
  • Kelishadi, R., Z. Farajzadegan, and M. Bahreynian. 2014. Association between vitamin D status and lipid profile in children and adolescents: A systematic review and meta-analysis. International Journal of Food Sciences and Nutrition 65 (4):404–10. doi: 10.3109/09637486.2014.886186.
  • Kennel, K. A., M. T. Drake, and D. L. Hurley. 2010. Vitamin D deficiency in adults: When to test and how to treat. Mayo Clinic Proceedings 85 (8):752. quiz 57-8. doi: 10.4065/mcp.2010.0138.
  • Keum, N., D. H. Lee, D. C. Greenwood, J. E. Manson, and E. Giovannucci. 2019. Vitamin D supplementation and total cancer incidence and mortality: A meta-analysis of randomized controlled trials. Annals of Oncology: Official Journal of the European Society for Medical Oncology 30 (5):733–43. doi: 10.1093/annonc/mdz059.
  • Khafaei, M., M. Sadeghi Hajiabadi, and A. Abdolmaleki. 2021. Role of 1, 25-dihydroxycholecalciferol in immunological and molecular pathways involved in multiple sclerosis. Central Asian Journal of Medical and Pharmaceutical Sciences Innovation 1:55–66.
  • Khoshbin, K., and M. Camilleri. 2020. Effects of dietary components on intestinal permeability in health and disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 319 (5):G589–G608. doi: 10.1152/ajpgi.00245.2020.
  • Kim, D., and J. Kim. 2016. Age and sex differences in the relationship between serum 25-hydroxyvitamin D and hypertension in the general Korean population. European Journal of Clinical Nutrition 70 (3):326–32. doi: 10.1038/ejcn.2015.115.
  • Kim, D. H., C. A. Meza, H. Clarke, J. S. Kim, and R. C. Hickner. 2020. Vitamin D and endothelial function. Nutrients 12 (2):575. doi: 10.3390/nu12020575.
  • Kim, Y. A., J. W. Yoon, Y. Lee, H. J. Choi, J. W. Yun, E. Bae, S.-H. Kwon, S. E. Ahn, A.-R. Do, H. Jin, et al. 2021. Unveiling genetic variants underlying vitamin D deficiency in multiple Korean cohorts by a genome-wide association study. Endocrinology and Metabolism (Seoul, Korea) 36 (6):1189–200. doi: 10.3803/EnM.2021.1241.
  • Ko, E. J., B. H. Kim, H. Y. Jeong, S. U. Soe, D. H. Yang, and S. Y. Lee. 2016. Serum 25-hydroxyvitamin D as a predictor of hospitalization-free survival in predialysis and dialysis patients with chronic kidney disease: A single-center prospective observational analysis. Kidney Research and Clinical Practice 35 (1):22–8. doi: 10.1016/j.krcp.2015.12.004.
  • Koeffler, H. P., H. Reichel, J. E. Bishop, and A. W. Norman. 1985. γ-Interferon stimulates production of 1, 25-dihydroxyvitamin D3 by normal human macrophages. Biochemical and Biophysical Research Communications 127 (2):596–603. doi: 10.1016/s0006-291x(85)80202-3.
  • Korkmaz, F. N., G. Ozen, A. U. Unal, A. Odabasi, M. Can, E. Asıcıoglu, S. Tuglular, and H. Direskeneli. 2022. Vitamin D levels in patients with small and medium vessel vasculitis. Reumatol Clin (Engl Ed) 18 (3):141–6. doi: 10.1016/j.reuma.2020.11.004.
  • Kragt, J., B. van Amerongen, J. Killestein, C. Dijkstra, B. Uitdehaag, C. Polman, and P. Lips. 2009. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Multiple Sclerosis (Houndmills, Basingstoke, England) 15 (1):9–15. doi: 10.1177/1352458508095920.
  • Krishnan, A. V., and D. Feldman. 2010. Molecular pathways mediating the anti-inflammatory effects of calcitriol: Implications for prostate cancer chemoprevention and treatment. Endocrine-Related Cancer 17 (1):R19–38. doi: 10.1677/ERC-09-0139.
  • Kang, S. W., S. H. Kim, N. Lee, W.-W. Lee, K.-A. Hwang, M. S. Shin, S.-H. Lee, W.-U. Kim, and I. Kang. 2012. 1, 25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. Journal of Immunology (Baltimore, Md.: 1950) 188 (11):5276–82. doi: 10.4049/jimmunol.1101211.
  • Lacour, B., C. Basile, T. Drüeke, and J. L. Funck-Brentano. 1982. Parathyroid function and lipid metabolism in the rat. Mineral and Electrolyte Metabolism 7:157–65.
  • Laursen, J. H., H. B. Søndergaard, P. S. Sørensen, F. Sellebjerg, and A. B. Oturai. 2016. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Multiple Sclerosis and Related Disorders 10:169–73. doi: 10.1016/j.msard.2016.10.005.
  • Lee, D. Y., A. R. Kwon, J. M. Ahn, Y. J. Kim, H. W. Chae, D. H. Kim, and H. S. Kim. 2015. Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010. Annals of Pediatric Endocrinology & Metabolism 20 (1):46–52. doi: 10.6065/apem.2015.20.1.46.
  • Lee, S. Y., H. Y. Kim, S. W. Gu, H. J. Kim, and D. H. Yang. 2012. 25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease. Kidney & Blood Pressure Research 35 (5):349–54. doi: 10.1159/000335952.
  • Leung, R. Y., Y. Han, C. W. Sing, B. M. Cheung, I. C. Wong, K. C. Tan, A. W. Kung, and C. L. Cheung. 2017. Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese. Thrombosis and Haemostasis 117 (1):158–63. doi: 10.1160/TH16-07-0551.
  • Lhamo, Y., P. K. Chugh, and C. D. Tripathi. 2016. Vitamin D supplements in the Indian market. Indian Journal of Pharmaceutical Sciences 78 (1):41–7. doi: 10.4103/0250-474x.180248.
  • Li, P., X. Xu, E. Cao, B. Yu, W. Li, M. Fan, M. Huang, L. Shi, R. Zeng, X. Su, et al. 2014. Vitamin D deficiency causes defective resistance to Aspergillus fumigatus in mice via aggravated and sustained inflammation. PLoS One 9 (6):e99805. doi: 10.1371/journal.pone.0099805.
  • Li, Y. C., J. Kong, M. Wei, Z. F. Chen, S. Q. Liu, and L. P. Cao. 2002. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation 110 (2):229–38. doi: 10.1172/JCI0215219.
  • Li, Y. C., G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, and J. Kong. 2004. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. The Journal of Steroid Biochemistry and Molecular Biology 89-90 (1-5):387–92. doi: 10.1016/j.jsbmb.2004.03.004.
  • Liang, S., J. Cai, Y. Li, and R. Yang. 2019. 1, 25-Dihydroxy-vitamin D3 induces macrophage polarization to M2 by upregulating T-cell Ig-mucin-3 expression. Molecular Medicine Reports 19 (5):3707–13. doi: 10.3892/mmr.2019.10047.
  • Lima, L. A. R., M. J. P. Lopes, R. O. Costa, F. A. V. Lima, K. R. T. Neves, I. B. F. Calou, G. M. Andrade, and G. S. B. Viana. 2018. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats. Journal of Neuroinflammation 15 (1):249. doi: 10.1186/s12974-018-1266-6.
  • Liu, N., L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison. 2008. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149 (10):4799–808. doi: 10.1210/en.2008-0060.
  • Liu, Y., X. Wang, X. Sun, S. Lu, and S. Liu. 2018. Vitamin intake and pancreatic cancer risk reduction: A meta-analysis of observational studies. Medicine 97 (13):e0114. doi: 10.1097/MD.0000000000010114.
  • Liu, W., L. Zhang, H. J. Xu, Y. Li, C. M. Hu, J. Y. Yang, and M. Y. Sun. 2018. The anti-inflammatory effects of vitamin D in tumorigenesis. International Journal of Molecular Sciences. 19 (9):2736. doi: 10.3390/ijms19092736.
  • Lopes, N., J. Carvalho, C. Duraes, B. Sousa, M. Gomes, J. L. Costa, … F. Schmitt. 2012. 1Alpha, 25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Research 32 (1):249–57.
  • Luckey, D., D. Bastakoty, and A. K. Mangalam. 2011. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: Studies using HLA transgenic mice. Journal of Autoimmunity 37 (2):122–8. doi: 10.1016/j.jaut.2011.05.001.
  • Ma, Y., P. Zhang, F. Wang, J. Yang, Z. Liu, and H. Qin. 2011. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29 (28):3775–82. doi: 10.1200/JClinOncol.2011.35.7566.
  • Maestro, B., S. Molero, S. Bajo, N. Dávila, and C. Calle. 2002. Transcriptional activation of the human insulin receptor gene by 1, 25‐dihydroxyvitamin D3. Cell Biochemistry and Function 20 (3):227–32. doi: 10.1002/cbf.951.
  • Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454 (7203):436–44. doi: 10.1038/nature07205.
  • Mathieu, C., and K. Badenhoop. 2005. Vitamin D and type 1 diabetes mellitus: State of the art. Trends in Endocrinology and Metabolism: TEM 16 (6):261–6. doi: 10.1016/j.tem.2005.06.004.
  • Mazur, A.,P. Frączek, andJ. Tabarkiewicz. 2022. Vitamin D as a Nutri-Epigenetic Factor in Autoimmunity-A Review of Current Research and Reports on Vitamin D Deficiency in Autoimmune Diseases. Nutrients 14 (20). doi: 10.3390/nu14204286. 36296970
  • Miliku, K., A. Vinkhuyzen, L. M. Blanken, J. J. McGrath, D. W. Eyles, T. H. Burne, A. Hofman, H. Tiemeier, E. A. Steegers, R. Gaillard, et al. 2016. Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and risks of adverse birth outcomes. The American Journal of Clinical Nutrition 103 (6):1514–22. doi: 10.3945/ajcn.115.123752.
  • Mimura, L. A. N., T. F. C. Fraga-Silva, L. R. C. Oliveira, L. L. W. Ishikawa, P. A. Borim, C. M. Machado, J. Júnior, D. M. D. Fonseca, and A. Sartori. 2021. Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol. International Journal of Molecular Sciences. 22 (4):1914. doi: 10.3390/ijms22041914.
  • Moreno, J., A. V. Krishnan, S. Swami, L. Nonn, D. M. Peehl, and D. Feldman. 2005. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Research 65 (17):7917–25. doi: 10.1158/0008-5472.CAN-05-1435.
  • Munger, K. L., L. I. Levin, B. W. Hollis, N. S. Howard, and A. Ascherio. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296 (23):2832–8. doi: 10.1001/jama.296.23.2832.
  • Mustafa, G., M. A. Asadi, I. Iqbal, and N. Bashir. 2018. Low vitamin D status in nursing Pakistani mothers in an environment of ample sunshine: A cross-sectional study. BMC Pregnancy and Childbirth 18 (1):426. doi: 10.1186/s12884-018-2062-0.
  • Nair, R., and A. Maseeh. 2012. Vitamin D: The "sunshine" vitamin. Journal of Pharmacology & Pharmacotherapeutics 3:118–26.
  • Nemerovski, C. W., M. P. Dorsch, R. U. Simpson, H. G. Bone, K. D. Aaronson, and B. E. Bleske. 2009. Vitamin D and cardiovascular disease. Pharmacotherapy 29 (6):691–708. doi: 10.1592/phco.29.6.691.
  • Nonn, L., L. Peng, D. Feldman, and D. M. Peehl. 2006. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: Implications for prostate cancer prevention by vitamin D. Cancer Research 66 (8):4516–24. doi: 10.1158/0008-5472.CAN-05-3796.
  • Norman, A. W. 2008. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. The American Journal of Clinical Nutrition 88 (2):491s–9S. doi: 10.1093/ajcn/88.2.491S.
  • Oh, J., S. Weng, S. K. Felton, S. Bhandare, A. Riek, B. Butler, B. M. Proctor, M. Petty, Z. Chen, K. B. Schechtman, et al. 2009. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120 (8):687–98. doi: 10.1161/CIRCULATIONAHA.109.856070.
  • Oh, J., A. E. Riek, S. Weng, M. Petty, D. Kim, M. Colonna, M. Cella, and C. Bernal-Mizrachi. 2012. Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. The Journal of Biological Chemistry 287 (15):11629–41. doi: 10.1074/jbc.M111.338673.
  • Ortona, E., F. Delunardo, A. Maselli, M. Pierdominici, and W. Malorni. 2015. Sex hormones and gender disparity in immunity and autoimmunity. Italian Journal of Gender-Specific Medicine 1 (2):45–50.
  • Overbergh, L., B. Decallonne, M. Waer, O. Rutgeerts, D. Valckx, K. M. Casteels, J. Laureys, R. Bouillon, and C. Mathieu. 2000. 1alpha, 25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49 (8):1301–7. doi: 10.2337/diabetes.49.8.1301.
  • Oliveri, B., L. Plantalech, A. Bagur, A. C. Wittich, G. Rovai, E. Pusiol, J. López Giovanelli, G. Ponce, A. Nieva, A. Chaperón, et al. 2004. High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. European Journal of Clinical Nutrition 58 (2):337–42. doi: 10.1038/sj.ejcn.1601786.
  • Ozcan, O. U., A. Gurlek, E. Gursoy, D. M. Gerede, and C. Erol. 2015. Relation of vitamin D deficiency and new-onset atrial fibrillation among hypertensive patients. Journal of the American Society of Hypertension: JASH 9 (4):307–12. doi: 10.1016/j.jash.2015.01.009.
  • Palacios, C., and L. Gonzalez. 2014. Is vitamin D deficiency a major global public health problem? The Journal of Steroid Biochemistry and Molecular Biology 144 Pt A:138–45. doi: 10.1016/j.jsbmb.2013.11.003.
  • Parhofer, K. G. 2015. Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia. Diabetes & Metabolism Journal 39 (5):353–62. doi: 10.4093/dmj.2015.39.5.353.
  • Pereira, F., A. Barbachano, J. Silva, F. Bonilla, M. J. Campbell, A. Munoz, and M. J. Larriba. 2011. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Human Molecular Genetics 20 (23):4655–65. doi: 10.1093/hmg/ddr399.
  • Pfeifer, M., B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen. 2001. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. The Journal of Clinical Endocrinology and Metabolism 86 (4):1633–7. doi: 10.1210/jc.86.4.1633.
  • Piazuelo, E., and A. Lanas. 2015. NSAIDS and gastrointestinal cancer. Prostaglandins & Other Lipid Mediators 120:91–6. doi: 10.1016/j.prostaglandins.2015.06.001.
  • Ponda, M. P., X. Huang, M. A. Odeh, J. L. Breslow, and H. W. Kaufman. 2012. Vitamin D may not improve lipid levels: A serial clinical laboratory data study. Circulation 126 (3):270–7. doi: 10.1161/CIRCULATIONAHA.111.077875.
  • Poon, A. H., L. Gong, C. Brasch-Andersen, A. A. Litonjua, B. A. Raby, Q. Hamid, C. Laprise, S. T. Weiss, R. B. Altman, and T. E. Klein. 2012. Very important pharmacogene summary for VDR. Pharmacogenetics and Genomics 22 (10):758–63. doi: 10.1097/FPC.0b013e328354455c.
  • Qi, D., X. Nie, and J. Cai. 2017. The effect of vitamin D supplementation on hypertension in non-CKD populations: A systemic review and meta-analysis. International Journal of Cardiology 227:177–86. doi: 10.1016/j.ijcard.2016.11.040.
  • Rapson, I. R., E. D. Michos, A. Alonso, A. T. Hirsch, K. Matsushita, J. P. Reis, and P. L. Lutsey. 2017. Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort. Atherosclerosis 257:123–9. doi: 10.1016/j.atherosclerosis.2017.01.016.
  • Rawson, J. B., Z. Sun, E. Dicks, D. Daftary, P. S. Parfrey, R. C. Green, S. Gallinger, J. R. McLaughlin, P. P. Wang, J. A. Knight, et al. 2012. Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients. Nutrition and Cancer 64 (7):919–28. doi: 10.1080/01635581.2012.711418.
  • Razzaque, M. S. 2011. The dualistic role of vitamin D in vascular calcifications. Kidney International 79 (7):708–14. doi: 10.1038/ki.2010.432.
  • Reich, K. M., R. N. Fedorak, K. Madsen, and K. I. Kroeker. 2014. Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review. World Journal of Gastroenterology 20 (17):4934–47. doi: 10.3748/wjg.v20.i17.4934.
  • Revez, J. A., T. Lin, Z. Qiao, A. Xue, Y. Holtz, Z. Zhu, J. Zeng, H. Wang, J. Sidorenko, K. E. Kemper, et al. 2020. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nature Communications 11 (1):1647. doi: 10.1038/s41467-020-15421-7.
  • Riek, A. E., J. Oh, I. Darwech, C. E. Moynihan, and R. R. Bruchas. 2014. Carlos The Journal of steroid biochemistry Bernal-Mizrachi, and molecular biology. ‘25 (OH) Vitamin D Suppresses Macrophage Adhesion and Migration by Downregulation of ER Stress and Scavenger Receptor A1 in Type 2 Diabetes’ 144:172–9.
  • Rolf, L., A. H. Muris, R. Hupperts, and J. Damoiseaux. 2014. Vitamin D effects on B cell function in autoimmunity. Annals of the New York Academy of Sciences 1317 (1):84–91. doi: 10.1111/nyas.12440.
  • Rostand, S. G. 1997. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension (Dallas, Tex.: 1979) 30 (2 Pt 1):150–6. doi: 10.1161/01.hyp.30.2.150.
  • Rostand, S. G., and T. B. Drüeke. 1999. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney International 56 (2):383–92. doi: 10.1046/j.1523-1755.1999.00575.x.
  • Roy, A., R. Lakshmy, M. Tarik, N. Tandon, K. S. Reddy, and D. Prabhakaran. 2015. Independent association of severe vitamin D deficiency as a risk of acute myocardial infarction in Indians. Indian Heart Journal 67 (1):27–32. doi: 10.1016/j.ihj.2015.02.002.
  • Rusińska, A., P. Płudowski, M. Walczak, M. K. Borszewska-Kornacka, A. Bossowski, D. Chlebna-Sokół, J. Czech-Kowalska, A. Dobrzańska, E. Franek, E. Helwich, et al. 2018. Vitamin D supplementation guidelines for general population and groups at risk of vitamin D deficiency in Poland-recommendations of the polish society of pediatric endocrinology and diabetes and the expert panel with participation of national specialist consultants and representatives of scientific societies-2018 update. Frontiers in Endocrinology 9:246. doi: 10.3389/fendo.2018.00246.
  • Sachan, A., R. Gupta, V. Das, A. Agarwal, P. K. Awasthi, and V. Bhatia. 2005. High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. The American Journal of Clinical Nutrition 81 (5):1060–4. doi: 10.1093/ajcn/81.5.1060.
  • Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunological Reviews 212:8–27. doi: 10.1111/j.0105-2896.2006.00427.x.
  • Santoro, D., D. Caccamo, S. Lucisano, M. Buemi, K. Sebekova, D. Teta, and L. De Nicola. 2015. Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system. BioMed Research International 2015:145828. doi: 10.1155/2015/145828.
  • Schrader, L. I., D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion. 2007. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (12):2576–81. doi: 10.1161/ATVBAHA.107.153080.
  • Schleicher, R. L., M. R. Sternberg, A. C. Looker, E. A. Yetley, D. A. Lacher, C. T. Sempos, C. L. Taylor, R. A. Durazo-Arvizu, K. L. Maw, M. Chaudhary-Webb, et al. 2016. National estimates of serum total 25-Hydroxyvitamin D and metabolite concentrations measured by liquid chromatography–Tandem mass spectrometry in the US population during 2007–2010. The Journal of Nutrition 146 (5):1051–61. doi: 10.3945/jn.115.227728.
  • Sellner, J., J. Kraus, A. Awad, R. Milo, B. Hemmer, and O. Stüve. 2011. The increasing incidence and prevalence of female multiple sclerosis–a critical analysis of potential environmental factors. Autoimmunity Reviews 10 (8):495–502. doi: 10.1016/j.autrev.2011.02.006.
  • Sim, J. J., P. T. Lac, I. L. Liu, S. O. Meguerditchian, V. A. Kumar, D. A. Kujubu, and S. A. Rasgon. 2010. Vitamin D deficiency and anemia: A cross-sectional study. Annals of Hematology 89 (5):447–52. doi: 10.1007/s00277-009-0850-3.
  • Sintzel, M. B., M. Rametta, and A. T. Reder. 2018. Vitamin D and multiple sclerosis: A comprehensive review. Neurology and Therapy 7 (1):59–85. doi: 10.1007/s40120-017-0086-4.
  • Sîrbe, C., S. Rednic, A. Grama, and T. L. Pop. 2022. An update on the effects of vitamin D on the immune system and autoimmune diseases. International Journal of Molecular Sciences 23 (17):9784. doi: 10.3390/ijms23179784.
  • Sogomonian, R., H. Alkhawam, J. Jolly, N. Vyas, S. Ahmad, E. Moradoghli Haftevani, A. Al-Khazraji, D. Finkielstein, and T. J. Vittorio. 2016. Serum vitamin D levels correlate to coronary artery disease severity: A retrospective chart analysis. Expert Review of Cardiovascular Therapy 14 (8):977–82. doi: 10.1080/14779072.2016.1190273.
  • Somjen, D., Y. Weisman, F. Kohen, B. Gayer, R. Limor, O. Sharon, N. Jaccard, E. Knoll, and N. Stern. 2005. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111 (13):1666–71. doi: 10.1161/01.CIR.0000160353.27927.70.
  • Sugden, J. A., J. I. Davies, M. D. Witham, A. D. Morris, and A. D. Struthers. 2008. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine: A Journal of the British Diabetic Association 25 (3):320–5. doi: 10.1111/j.1464-5491.2007.02360.x.
  • Sultan, S., U. Taimuri, S. A. Basnan, W. K. Ai-Orabi, A. Awadallah, F. Almowald, and A. Hazazi. 2020. Low vitamin D and its association with cognitive impairment and dementia. Journal of Aging Research 2020:6097820.
  • Sun, X., Z. B. Cao, K. Tanisawa, T. Ito, S. Oshima, Y. Ishimi, I. Tabata, and M. Higuchi. 2015. Associations between the Serum 25(OH)D Concentration and Lipid Profiles in Japanese Men. Journal of Atherosclerosis and Thrombosis 22 (4):355–62. doi: 10.5551/jat.26070.
  • Tapp, H. S., D. M. Commane, D. M. Bradburn, R. Arasaradnam, J. C. Mathers, I. T. Johnson, and N. J. Belshaw. 2013. Nutritional factors and gender influence age‐related DNA methylation in the human rectal mucosa. Aging Cell 12 (1):148–55. doi: 10.1111/acel.12030.
  • Takiishi, T., C. Gysemans, R. Bouillon, and C. Mathieu. 2010. Vitamin D and diabetes. Endocrinology and Metabolism Clinics of North America 39 (2):419–46, table of contents. doi: 10.1016/j.ecl.2010.02.013.
  • Tarcin, O., D. G. Yavuz, B. Ozben, A. Telli, A. V. Ogunc, M. Yuksel, A. Toprak, D. Yazici, S. Sancak, O. Deyneli, et al. 2009. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. The Journal of Clinical Endocrinology and Metabolism 94 (10):4023–30. doi: 10.1210/jc.2008-1212.
  • Targher, G., L. Bertolini, R. Padovani, L. Zenari, L. Scala, M. Cigolini, and G. Arcaro. 2006. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clinical Endocrinology 65 (5):593–7. doi: 10.1111/j.1365-2265.2006.02633.x.
  • Te Riet, L., J. H. van Esch, A. J. Roks, A. H. van den Meiracker, and A. H. Danser. 2015. Hypertension: Renin-angiotensin-aldosterone system alterations. Circulation Research 116 (6):960–75. doi: 10.1161/CIRCRESAHA.116.303587.
  • Topilski, I., L. Flaishon, Y. Naveh, A. Harmelin, Y. Levo, and I. Shachar. 2004. The anti‐inflammatory effects of 1, 25‐dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin‐mediated T lymphocyte homing. European Journal of Immunology 34 (4):1068–76. doi: 10.1002/eji.200324532.
  • Tran, L. T., K. M. MacLeod, and J. H. McNeill. 2009. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Molecular and Cellular Biochemistry 330 (1-2):219–28. doi: 10.1007/s11010-009-0136-z.
  • Trasciatti, S., F. Piras, S. Bonaretti, S. Marini, S. Nencioni, E. Biasci, C. G. Egan, and F. Nannipieri. 2022. Effect of oral cholecalciferol in a murine model of celiac disease: A dose ranging study. The Journal of Steroid Biochemistry and Molecular Biology 220:106083. doi: 10.1016/j.jsbmb.2022.106083.
  • Urry, Z., E. Xystrakis, D. F. Richards, J. McDonald, Z. Sattar, D. J. Cousins, C. J. Corrigan, E. Hickman, Z. Brown, and C. M. Hawrylowicz. 2009. Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α, 25-dihydroxyvitamin D3 abrogates regulatory function. The Journal of Clinical Investigation 119 (2):387–98. doi: 10.1172/JCI32354.
  • van Etten, E., L. Verlinden, A. Giulietti, E. Ramos-Lopez, D. D. Branisteanu, G. B. Ferreira, L. Overbergh, A. Verstuyf, R. Bouillon, B. O. Roep, et al. 2007. The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system. European Journal of Immunology 37 (2):395–405. doi: 10.1002/eji.200636043.
  • Vanoirbeek, E., G. Eelen, L. Verlinden, G. Carmeliet, C. Mathieu, R. Bouillon, R. O’Connor, G. Xiao, and A. Verstuyf. 2014. PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and-invasion activity of vitamin D. Oncogene 33 (15):1904–11. doi: 10.1038/onc.2013.123.
  • Varol, C., E. Zigmond, and S. Jung. 2010. Securing the immune tightrope: Mononuclear phagocytes in the intestinal lamina propria. Nature Reviews. Immunology 10 (6):415–26. doi: 10.1038/nri2778.
  • Vici, G., D. Camilletti, and V. Polzonetti. 2020. Possible role of vitamin D in celiac disease onset. Nutrients 12 (4):1051. doi: 10.3390/nu12041051.
  • Wang, T. J., F. Zhang, J. B. Richards, B. Kestenbaum, J. B. van Meurs, D. Berry, D. P. Kiel, E. A. Streeten, C. Ohlsson, D. L. Koller, et al. 2010. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet (London, England) 376 (9736):180–8. doi: 10.1016/S0140-6736(10)60588-0.
  • Wang, Y., S. Si, J. Liu, Z. Wang, H. Jia, K. Feng, L. Sun, and S. J. Song. 2016. The associations of serum lipids with vitamin D status. PLoS One 11 (10):e0165157. doi: 10.1371/journal.pone.0165157.
  • Wasson, L. T., D. Shimbo, M. R. Rubin, J. A. Shaffer, J. E. Schwartz, and K. W. Davidson. 2011. Is vitamin D deficiency a risk factor for ischemic heart disease in patients with established cardiovascular disease? 10-year follow-up of the Nova Scotia Health Survey. International Journal of Cardiology 148 (3):387–9. doi: 10.1016/j.ijcard.2010.12.036.
  • Williams, J. D., A. Aggarwal, S. Swami, A. V. Krishnan, L. Ji, M. A. Albertelli, and B. J. Feldman. 2016. Tumor autonomous effects of vitamin D deficiency promote breast cancer metastasis. Endocrinology 157 (4):1341–7. doi: 10.1210/en.2015-2036.
  • Wimalawansa, S. J. 2019. Vitamin D deficiency: Effects on oxidative stress, epigenetics, gene regulation, and aging. Biology (Basel) 8 (2):30. doi: 10.3390/biology8020030.
  • Wu-Wong, J. R., M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger. 2006. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 186 (1):20–8. doi: 10.1016/j.atherosclerosis.2005.06.046.
  • Yamini, P., R. S. Ray, and K. Chopra. 2018. Vitamin D(3) attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer’s disease. Inflammopharmacology 26 (1):39–55. doi: 10.1007/s10787-017-0372-x.
  • Yang, C. Y., P. S. Leung, I. E. Adamopoulos, and M. E. Gershwin. 2013. The implication of vitamin D and autoimmunity: a comprehensive review. Clinical Reviews in Allergy & Immunology 45 (2):217–26. doi: 10.1007/s12016-013-8361-3.
  • Yoon, T., S. S. Ahn, J. Y. Pyo, J. J. Song, Y. B. Park, and S. W. Lee. 2022. Serum vitamin D level correlates with disease activity and health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis. Zeitschrift Für Rheumatologie 81 (1):77–84. doi: 10.1007/s00393-020-00949-2.
  • Yuan, L., R. Jiang, Y. Yang, S. Ding, and H. Deng. 2012. 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway. Oncology Reports 28 (6):2131–7. doi: 10.3892/or.2012.2031.
  • Yuan, W., W. Pan, J. Kong, W. Zheng, F. L. Szeto, K. E. Wong, R. Cohen, A. Klopot, Z. Zhang, and Y. C. Li. 2007. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. The Journal of Biological Chemistry 282 (41):29821–30. doi: 10.1074/jbc.M705495200.
  • Zeitz, U., K. Weber, D. W. Soegiarto, E. Wolf, R. Balling, and R. G. Erben. 2003. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB Journal: official Publication of the Federation of American Societies for Experimental Biology 17 (3):509–11. doi: 10.1096/fj.02-0424fje.
  • Zhang, Q. Y., C. M. Jiang, C. Sun, T. F. Tang, B. Jin, D. W. Cao, J. S. He, and M. Zhang. 2015. Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease. Journal of Nephrology 28 (4):471–6. doi: 10.1007/s40620-014-0167-8.
  • Zheng, S., J. Fan, F. Yu, B. Feng, B. Lou, Q. Zou, G. Xie, S. Lin, R. Wang, X. Yang, et al. 2020. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: Retrospective cohort study. BMJ (Clinical Research ed.) 369: M 1443. doi: 10.1136/bmj.m1443.
  • Zhou, C., F. Lu, K. Cao, D. Xu, D. Goltzman, and D. Miao. 2008. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney International 74 (2):170–9. doi: 10.1038/ki.2008.101.
  • Zittermann, A., S. S. Schleithoff, and R. Koerfer. 2005. Putting cardiovascular disease and vitamin D insufficiency into perspective. The British Journal of Nutrition 94 (4):483–92. doi: 10.1079/bjn20051544.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.